[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100614460":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":25,"responsibleParty":42,"collaborators":10,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":10,"eligibilityCriteria":52,"healthyVolunteers":53,"sex":54,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":64,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Karolinska Institutet","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Pre-implementation group (2017)",null,"Children who received standard systemic analgesia (intravenous and\u002For oral opioids, acetaminophen, and NSAIDs) without nerve block.",{"label":13,"type":10,"description":14,"interventionNames":10},"Post-implementation group (2018)","Children who, in addition to standard systemic analgesia, received a suprazygomatic maxillary nerve block (SZMNB) as part of routine perioperative care.",[16],{"name":17,"affiliation":5,"role":18},"Märit Lundblad, MD PhD","PRINCIPAL_INVESTIGATOR",[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Jacob KarlssonM, MD PhD","CONTACT","+460812370000","jacob.karlsson.1@ki.se",[26],{"facility":10,"status":27,"city":28,"state":10,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"RECRUITING","Stockholm","SE-171 76","Sweden","SE",{"type":33,"coordinates":34},"Point",[35,36],18.06871,59.32938,{"lat":36,"lon":35},[39],{"name":40,"role":22,"phone":10,"phoneExt":10,"email":41},"Märit Lundblad","marit.lundblad@regionstockholm.se",{"type":18,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":45,"oldNameTitle":10,"oldOrganization":10},"Jacob Karlsson","Associate Professor","Karolinska University Hospital","100614460","length-of-hospital-stay-and-postoperative-analgesic-requirements-after-introduction-of-a-specific-maxillary-nerve-block-in-children-undergoing-cleft-palate-surgery-100614460",false,"NCT07279883","Length of Hospital Stay and Postoperative Analgesic Requirements After Introduction of a Specific Maxillary Nerve Block in Children Undergoing Cleft Palate Surgery","Length of Hospital Stay and Postoperative Analgesic Requirements After Introduction of a Specific Maxillary Nerve Block in Children Undergoing Cleft Palate Surgery: a Before-and-after Chart Review Study","criteria for participating in the study\n\n* children aged 3 months to 15 years.\n* Underwent cleft palate (LKG) surgery between 2017-2018.\n* Available and complete medical records including perioperative notes, anesthesia documentation, and discharge summaries.\n* Received either standard systemic analgesia alone (2017) or standard analgesia plus suprazygomatic maxillary nerve block (SZMNB) (2018).\n\nExclusion Criteria: not fulfilling inclusion cirteria\n\n\\-",true,"ALL","3 Months","15 Years",{"count":58,"type":59},150,"ESTIMATED","OBSERVATIONAL","Cleft lip and palate (CLP) is one of the most common congenital malformations and requires repeated surgical correction during childhood. Surgical repair is often associated with significant postoperative pain, traditionally managed with morphine, which carries a risk of undesirable side effects. The suprazygomatic maxillary nerve block (SZMNB) has been shown to provide effective analgesia and may reduce the need for opioids.\n\nRoutine use of SZMNB was introduced at the pediatric surgery unit at Karolinska University Hospital in late 2017. A before-and-after evaluation project based on retrospective chart review was initiated in 2018 but was not completed due to the COVID-19 pandemic.\n\nThe aim of this project is to investigate whether the introduction of SZMNB has reduced postoperative morphine requirements and opioid-related side effects, and whether this has resulted in shorter hospital stays (earlier discharge) after cleft palate repair.",[63],"Cleft Palate Children",[65,66,67,68,69,70],"Cleft palate","Suprazygomatic maxillary nerve block","Pediatric anesthesia","Regional anesthesia","Nerve block","opiod consumtion","2025-12-10",{"date":73,"type":74},"2025-12-12","ACTUAL",{"date":76,"type":74},"2017-01-01",{"date":78,"type":59},"2025-12-31",{"name":5,"class":6},1]